Salt CompositionYou Searched
Oxyprim Capsule
M. Frank Pharmaceuticals
₹62.5
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Treatment of Gout
Customers also bought
More About Oxyprim Capsule
Benefits
In Treatment of Gout Oxyprim Capsule is used to prevent and treat gout. Gout is caused by too much uric acid in your body. When the level becomes too high, crystals may form in and around certain joints and your kidneys. This can cause sudden and severe pain, redness, warmth, and swelling. This medicine works by preventing crystals from forming and reducing the levels of uric acid in your blood. This makes it less likely that you will suffer the symptoms and make them milder if you do have them. It is usually for long-term treatment and should be taken regularly until the dose is completed.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Oxyprim Capsule is to be taken with food.
How it works
Oxyprim Capsule is a xanthine oxidase inhibitor. It works by decreasing blood uric acid, which is the chemical that causes gout.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Oxyprim Capsule .
Seek medical advice from your doctor: Oxyprim Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: Oxyprim Capsule is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Not Safe: Oxyprim Capsule may cause side effects which could affect your ability to drive. Occasionally drowsiness, dizziness or vertigo, ataxia and visual disturbances, may occur when taking Oxyprim Capsule. This may affect your driving ability.
Caution Advised: Oxyprim Capsule should be used with caution in patients with kidney disease. Dose adjustment of Oxyprim Capsule may be needed. Doctor consultation is advised.
Caution Advised: Oxyprim Capsule should be used with caution in patients with liver disease. Dose adjustment of Oxyprim Capsule may be needed. Doctor consultation is advised.
What if I forget to take it?
If a dose of Oxyprim Capsule is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
References
Furst DE, Ulrich RW, Varkey-Altamirano C. Nonsteroidal Anti-Inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Nonopioids Analgesics, & Drugs Used in Gout. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 638-39
Grosser T, Smyth E, FitzGerald GA. Anti-Inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 996-97
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 40-42
CiplaMed: Allopurinol (16 Mar. 2025)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
